These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20332437)

  • 1. Sulindac sulfone induces a decrease of beta-catenin in HNSCC.
    Sauter A; Soulsby H; Hormann K; Naim R
    Anticancer Res; 2010 Feb; 30(2):339-43. PubMed ID: 20332437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive alteration of the cell-cell adhesion in head and neck squamous cell cancer.
    Naim R; Chang RC; Schultz J; Hormann K
    Oncol Rep; 2006 Aug; 16(2):273-7. PubMed ID: 16820902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac sulfone modulates beta-catenin in human cholesteatoma cell culture.
    Sauter A; Matharu R; Braun T; Schultz J; Sadick H; Hormann K; Naim R
    Arch Med Res; 2007 May; 38(4):367-71. PubMed ID: 17416281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Schultz JD; Sommer JU; Hoedt S; Erben P; Hofheinz RD; Faber A; Thorn C; Hörmann K; Sauter A
    Oncol Rep; 2012 Jan; 27(1):270-80. PubMed ID: 21993766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC.
    Chang WC; Everley LC; Pfeiffer GR; Cooper HS; Barusevicius A; Clapper ML
    Ann N Y Acad Sci; 2005 Nov; 1059():41-55. PubMed ID: 16382042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
    Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
    Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F; Zeng Q; Yu G; Li S; Wang CY
    Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG; Hamburger AW; Sauk JJ
    Cancer Res; 2002 Feb; 62(4):1004-7. PubMed ID: 11861373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Umbreit C; Aderhold C; Faber A; Sommer JU; Sauter A; Hofheinz RD; Stern-Sträter J; Hoermann K; Schultz JD
    Anticancer Res; 2013 Jun; 33(6):2457-65. PubMed ID: 23749896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
    Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.
    Cohen AN; Veena MS; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):190-7. PubMed ID: 19221248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
    Lotan R
    Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.